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G1 cyclins, in association with a cyclin-dependent kinase (CDK), are universal activators of the transcriptional G1-S machinery
during entry into the cell cycle. Regulation of cyclin degradation is crucial for coordinating progression through the cell cycle,
but the mechanisms that modulate cyclin stability to control cell cycle entry are still unknown. Here, we show that a lack of phos-
phate downregulates Cln3 cyclin and leads to G1 arrest in Saccharomyces cerevisiae. The stability of Cln3 protein is diminished
in strains with low activity of Pho85, a phosphate-sensing CDK. Cln3 is an in vitro substrate of Pho85, and both proteins interact
in vivo. More interestingly, cells that carry a CLN3 allele encoding aspartic acid substitutions at the sites of Pho85 phosphoryla-
tion maintain high levels of Cln3 independently of Pho85 activity. Moreover, these cells do not properly arrest in G1 in the ab-
sence of phosphate and they die prematurely. Finally, the activity of Pho85 is essential for accumulating Cln3 and for reentering
the cell cycle after phosphate refeeding. Taken together, our data indicate that Cln3 is a molecular target of the Pho85 kinase that
is required to modulate cell cycle entry in response to environmental changes in nutrient availability.
When environmental conditions change, Saccharomyces cerevi-siae, like other organisms, takes several coordinated decisions
about growth, cell division, and maintaining homeostasis. Nutrient
status is among the most important environmental conditions that
must be accurately sensed and responded to in order to ensure cell
survival. In the absence of nutrients, cells arrest in G1 phase, and this
regulation of cell cycle becomes essential in the adaptation process.
However, nothing is known about hownutrients impinge on the cell
cycle machinery (1).
In budding yeast, the commitment to a new round of cell divi-
sion takes place in late G1, at a point called Start, where transcrip-
tional activation of more than 200 G1-specific genes occurs (re-
viewed in reference 2). This includes the transcription of major
cell cycle regulators, including the G1 cyclins Cln1, Cln2, Clb5,
and Clb6, as well as numerous genes with functions related to
DNA metabolism, budding, spindle pole body duplication, and
cell wall synthesis (3, 4). Many of these transcribed genes are tar-
gets of the heterodimeric transcription factors SBF andMBF, each
of which contains a Swi6 subunit and a distinct DNA-binding
subunit: Swi4 and Mbp1, respectively (5). It is interesting to note
that, when SBF and MBF are poised at their target promoters
during much of G1 phase, they cannot activate transcription;
rather, they repress it (6, 7). To become activators at Start, they
need an upstream element: the Cdc28/Cln3 complex.
Cdc28 is a cyclin-dependent kinase (CDK) that governs all of
the cell cycle progression, and Cln3 is a highly unstable cyclin that
remains fairly constant throughout the cell cycle (8, 9). When
Cdc28 is associated with Cln3 cyclin, it unfolds the activation of
transcriptional G1 machinery, chiefly through two mechanisms:
phosphorylation of theWhi5 repressor (and presumably of Swi6)
at multiple residues (10–12) and control of the Stb1 dual protein
and the histone deacetylases (13). In addition to Cln3, other ele-
ments involved in G1 transcription firing have recently been dem-
onstrated: for example, a positive-feedback mechanism involving
Cln1 and Cln2 could reinforce SBF/MBF activation (14). At the
end of G1, the rise in Cln/Cdc28 activity results in the phosphor-
ylation and targeting for degradation of Sic1, an inhibitor of the
S-phase cyclins, thereby enabling robust entry into S-phase (15).
Nutrients are important trophic factors that control the pas-
sage through Start by activating several signaling pathways, in-
cluding the protein kinase A and Snf1 pathways, which positively
regulate cell proliferation in response to glucose availability (16),
and the TORC1 pathway, which controls the cell cycle according
to nitrogen levels (17). Consequently, inactivation of any of three
major pathways results in a cell cycle blockade and, in other typical
phenotypes, of the G0-like growth arrest program, even in the
presence of other abundant nutrients. Due to its role as the most
upstream activator, Cln3 has emerged as a good target for these
pathways. Indeed, it has been demonstrated that this cyclin be-
comes less stable under nitrogen deprivation, although the mech-
anism(s) underlying this effect remains obscure (18).
Phosphate is sensed by another signaling pathway, the PHO
pathway, which has progressively been uncovered by the O’Shea
group (19). The central element of this pathway is another CDK:
Pho85, which associates with a family of 10 cyclins, each of which
can direct Pho85 to different substrates (for a review, see reference
20). Pho80 is themain cyclin of the PHOpathway, which controls
phosphate homeostasis, and Pho81 is the corresponding CDK in-
hibitor (21). The phosphate sensor that controls this pathway is
still unknown: however, a low-Pi signal is known to be transmitted
via certain inositol polyphosphate (IP) species (e.g., heptakispho-
sphate [IP7]), which are synthesized byVip1 IP6 kinase. IP7 appar-
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ently interacts noncovalently with the Pho80/Pho85/Pho81 com-
plex and induces additional interactions between Pho81 and
Pho80/Pho85, preventing substrates from accessing the active site
of the kinase (19, 22). Thus, the ternary complex Pho80/Pho81/
Pho85 is active in richmediumbutbecomes inactiveuponphosphate
starvation, leading to themigration of unphosphorylated Pho4 tran-
scription factor into the nucleus and enabling the expression or re-
pression of PHO genes (21, 23, 24). This transcriptional response
ultimately results in maintenance of the internal phosphate levels.
Besides being constitutively associated with Pho80, Pho85 is
also bound to other cyclins (e.g., Pcl1, Pcl2, and Pcl9) (20). In fact,
the four Pho85 complexes should be considered different en-
zymes: they recognize different substrates, they are localized in
different subcellular regions, and the respective activities of the
Pcl1/Pho85, Pcl2/Pho85, and Pcl9/Pho85 complexes are not reg-
ulated by external phosphate. When Pho85 is associated with
these Pcl cyclins, it cooperates with Cdc28 in specific morphoge-
netic events during the G1-S transition.
It is logical to wonder whether Pho80/Pho85 complexes could
also help control the cell cycle. Indeed, there is evidence that
Pho80/Pho85 phosphorylates and inhibits Rim15, a PAS kinase
that promotes the entry into the G0 program in stationary cells
(25), although whether this mechanism is involved in cell cycle-
induced arrest is unknown. In addition, it has been demonstrated
that Pho80/Pho85 is essential to restart the cell cycle after G1 arrest
due to DNA damage (26), suggesting that the Pho85 activity is
essential when Cdc28 activity is absent (20).
Here, we demonstrate that the lack of phosphate leads to
downregulation of Cln3 protein levels and to G1 arrest. Interest-
ingly, neither effect is observed in cells that overexpress Pho85 or
in cells that cannot inhibit it (i.e., vip1 or pho81 cells). In ac-
cordance, we also demonstrate that Cln3 is less stable in strains
with low Pho85/Pho80 activity and that it is phosphorylated in
vitro by Pho85/Pho80 complexes at S449 and T520. More inter-
estingly, we report that cells carrying a CLN3 allele encoding as-
partic acid substitutions at these sites maintain high levels of Cln3
independently of Pho85 activity. Accordingly, the nonphosphor-
ylatable alaninemutant displays the same low levels as the pho85
mutant. Finally, we show that when nutrient levels drop, down-
regulation of Cln3 is essential to establish proper G1 arrest and
that once these levels recuperate, activation of Pho85 is essential to
restart the cell cycle from the G0 state. Together, our findings
indicate that phosphate levels regulate the amount of Cln3 by
controlling Pho85/Pho80 kinase activity.
MATERIALS AND METHODS
Strains. The strains used are indicated in Table 1. The pho85-as strain
(YAM67, which carries an analog-sensitive allele of PHO85) was provided
by ErinO’Shea andwas used for inhibition of Pho85 in the presence of the
inhibitor 1-Na PP1; (4-amino-1-tert-butyl-3-(1=-naphthylpyrazolo[3,4-
D]pyrimidine) kindly provided byK. Shokat) as described previously (27).
The Pho85 inhibitionwas confirmed by following the entry of Pho4-green
fluorescent protein (GFP) into the nucleus.
Plasmids. The plasmids used in this work are listed in Table 2. CLN3-
MYC was expressed from its own promoter in the centromeric plasmid
pRS416; this plasmid expressesCLN3 at a level similar to the expression of
the genomic tagged version. To expressMYC-tagged mutated versions of
CLN3, we replaced S449 and T520 with alanine or used the substitutions
I448D S449D and T519 T520D to mimic the double-negative charge of
the phosphate group. PHO85 and Pho80 were overexpressed under the
control of theGAL1 promoter in the pEG(KG) plasmid. YAM91 carries a
plasmidwithCLN3 hemagglutinin (HA)-tagged protein lacking the PEST
sequence of CLN3 (the cln3-1-HA allele). The CLN2 open reading frame
(ORF) was placed under the control of the Schizosaccharomyces pombe
adh1 promoter in YCplac22 (28), resulting in plasmid pCM64. Recombi-
nant proteins were expressed from the pGEX6P1 plasmid. Due to its tox-
icity in Escherichia coli cells, full-length Cln3 could not be expressed, and
the C-terminal half of Cln3 (fromMet 347 to Arg 580) was cloned into the
BamHI site of pGEX6P1 (pJC1154).
Growth conditions. Cells were grown in either YPD medium (1%
yeast extract, 2% peptone, and 2% glucose) or complete synthetic dex-
trose (SD) medium (0.67% yeast nitrogen base and 2% glucose) contain-
ing amino acids for auxotrophic requirements (15g/ml leucine, 5g/ml
histidine, and 10 g/ml tryptophan).
Yeast nitrogen base without phosphate was used as recommended by
the manufacturer (MP Biomedicals) to prepare SD medium without a
phosphate source. Phosphate deprivation experiments were done with
cells growing exponentially in SD for 14 to 16 h until they reached an
optical density at 600 nm (OD600) of 0.3 to 0.4, at which point the cells
were collected by filtration and, after a quick wash, resuspended at the
same cellular concentration in prewarmedmedium lacking the phosphate
source, as previously described (18). The nitrogen deprivation experi-
ment was performed under the same conditions using a yeast nitrogen
base without ammonium sulfate (Difco). -Factor cell synchrony exper-
iments were done as previously described (29).
DNA content, cell volume, cell number, and budding index mea-
surements. Approximately 1 107 cells were collected and processed as
described previously (30). DNA was stained with SYBR green and then
analyzed in a FACSCalibur cytometer (Becton Dickinson). Cell number
and volumewere quantified using a Scepter cell counter (Millipore). Bud-
ding was analyzed microscopically by scoring a minimum of 200 cells.
Immunoblot analysis.The primary anti-Myc or anti-HAmonoclonal
antibodies (kindly provided by F. Posas) were used at 1:100 and followed
by anti-mouse-horseradish peroxidase (HRP)-conjugated anti-mouse
secondary antibody (1:20,000), using SuperSignal West Femto chemilu-
minescent substrate (Thermo Scientific). Anti-glucose-6-phosphate de-
hydrogenase (anti-G6PDH; Sigma) was used at 1:500.
Coimmunoprecipitation of PHO85-TAP and CLN3-MYC. Expo-
nential-phase yeast cells were harvested (500 ml at an OD600 of 0.7) and
resuspended in 5ml of cold extraction buffer A (50mMTris, pH8, 15mM
EDTA, 15mMEGTA, 0.1% Triton X-100) containing protease inhibitors
(2 g/ml each of pepstatin, leupeptin, phenylmethylsulfonyl fluoride
[PMSF], and benzamidine) and phosphatase inhibitors (10 mM sodium
orthovanadate and 250mM-glycerophosphate). Cells were ruptured by
vortexingwith glass beads, and the resulting extract was centrifuged at 4°C
for 1 h at 12,000 rpm. Amounts of 3 mg of crude extracts were incubated
for 2 h at 4°C with 150 l of IgG-Sepharose beads (Amersham Biosci-
ences). After washing with extraction buffer, the proteins bound to the
beads were resuspended in 30 l of SDS-PAGE sample buffer, heated at
95°C for 5 min, and loaded onto SDS-PAGE gels.
Recombinant protein purification. For expression of glutathione S-
transferase (GST) or GST fusion proteins, Escherichia coli strain
BL21(DE3) (Stratagene) was transformed with the corresponding plas-
mids. Protein expression was induced with 1 mM isopropyl -D-thioga-
lactopyranoside for 3 h at 25°C. Cells were collected by centrifugation,
resuspended in 600 l of phosphate-buffered saline with 0.1% Triton
X-100 (PBS-T) supplemented with a protease inhibitor mixture (Roche Ap-
plied Science), and subjected to mechanical rupture. The cell debris was re-
moved by centrifugation, and the supernatants were purified using glutathi-
one-Sepharose column chromatography, as described in the manufacturer’s
protocol. After incubation for 2 h at 4°C with rotation, the beads were col-
lected by centrifugation (1,000 rpm for 1min at 4°C) andwashedwithPBS-T
three times. The elution was performed by adding 10mM glutathione.
Kinase assays. Kinase assays were performed essentially as described
previously (31). GST-Pho85 and GST-Pho80 were purified from bacteria
as described above. A fragment of GST-Cln3 was expressed (plasmid
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pJC1154) and purified from bacteria. Cdc28-TAP was purified using IgG
Sepharose beads (Sigma). Phosphorylated proteinswere detected by using
the Pro-Q diamond phosphoprotein gel stain kit (Invitrogen).
Viability assays. The viability experiments were done as described in
reference 32. Stationary-phase cells were diluted, plated in YPD, and in-
cubated for 2 days.
RNA isolation and analysis. Cells were harvested and stored at
80°C. Total RNA was isolated by hot phenol extraction and quantified
spectrophotometrically. An amount of 2 g of total RNA was incubated
with DNase and reverse transcribed using Quanta qScript cDNA super-
mix following the manufacturer’s instructions. The cDNA was subjected
to reverse transcription (RT)-PCRon aC1000 thermal cycler-CFX96 real-
time PCR system, and expression was normalized to that of CDC28.
RESULTS
TheG1 arrest caused by phosphate depletionmay involve active
mechanisms to downregulate Cdc28-Cln activity.Nutrients are
TABLE 1 Yeast strains used in this study
Strain Background Genotype Source
BY4741 BY4741 MATa his31 leu2200 met150 ura30 Euroscarf
YNR55 BY4741 CLN3-MYC-KanMX This study
YAM78 BY4741 pho85::LEU2 This study
YAM78 BY4741 pho85::LEU2 CLN3-MYC-KanMX This study
YAM113 BY4741 pRS416-CLN3-MYC This study
YAM114 BY4741 pho85::LEU2 pRS416-CLN3-MYC This study
YAM115 BY4741 pcl1::LEU2 pRS416-CLN3-MYC This study
YAM119 BY4741 pcl2::KanMX pcl1::LEU2 pRS416-CLN3-MYC This study
YAM116 BY4741 pcl6::KanMX pRS416-CLN3-MYC This study
YAM117 BY4741 pcl7::KanMX pRS416-CLN3-MYC This study
YAM118 BY4741 pcl8::KanMX pRS416-CLN3-MYC This study
YAM99 BY4741 pcl9::KanMX pRS416-CLN3-MYC This study
YAM111 BY4741 pho80::LEU2 pRS416-CLN3-MYC This study
YPC702 BY4741 SWI6-TAP-KanMX This study
YNR11 BY4741 WHI5-TAP-KanMX This study
YAM150 BY4741 vip1::KanMX pRS416-CLN3-MYC This study
YNR82 BY4741 pho81::LEU2 CLN3-MYC-KanMX This study
YAM63 BY4741 CLN3-MYC-KanMX pEG(KT)-GAL-PHO85 This study
YAM91 BY4741 pRS416-cln3-1-HA This study
YAM92 BY4741 pho85::LEU2 pRS416-CLN3-1-HA This study
YAM151 BY4741 ubc4::LEU2 CLN3-MYC-KanMX This study
YAM142 BY4741 pho85::URA ubc4::LEU2 CLN3-MYC-KanMX This study
YAM146 BY4741 PHO85-TAP-KanMX pRS416-CLN3-MYC This study
YNR13 BY4741 PHO85-TAP-KanMX This study
YAM113 BY4741 pRS416-CLN3-MYC This study
YAM163 BY4741 pRS416-CLN3-(T520A S449A-MYC) This study
YAM149 BY4741 pho85::LEU2 pRS416-CLN3-(T519D T520D I448D S449D-MYC) This study
YAM103 BY4741 pho80::LEU2 This study
YAM45 BY4741 pho81::LEU2 This study
YNR46 BY4741 vip1::KanMX This study
YPC631 BY4741 cln3::KanMX This study
YSH10 BY4741 atg1::LEU2 CLN3-MYC-KanMX This study
YSH11 BY4741 pho85::URA atg1::LEU2 CLN3-MYC-KanMX This study
YAM67 K699 pho85::LEU2 ADE2 PHO4-GFP trp1::PHO85(F82G)-TRP1 E. O’Shea
YAN32 W303 CLN2-HA-URA3 SIC1-MYC-KanMX CLB5-TAP-LEU2 F. Posas
TABLE 2 Plasmids used in this study
Name Relevant characteristics Reference or source
pCM64 YCplac22-ADHp-CLN2 14
pJC1065 pEG(KG)-PHO85 (cloned in BamHI) This study
pJC1437 pEG(KG)-PHO80 (cloned in BamHI) This study
pJC1280 pRS416-CLN3-MYC This study
pJC1161 pGEX6P1-PHO80 (cloned in BamHI) This study
pJC1164 pGEX6P1-PHO85 (cloned in BamHI) This study
pJC1154 pGEX6P1-CLN3 (from nucleotide 1038 to stop codon) This study
pJC1448 pGEX6P1-CLN3 (from nucleotide 1038 to stop codon) with the 2 putative Pho85 sites (S449 and T520) mutated to Asp This study
pJC1456 pGEX6P1-CLN3 (from nucleotide 1038 to stop codon) with the 2 putative Pho85 sites (S449 and T520) mutated to Ala This study
pJC1449 pGEX6P1-CLN3 (from nucleotide 1159 to stop codon) with the 8 putative Cdc28 sites (T420, S455, S462, S466, S466,
T478, S514, and T517) mutated to Ala
This study
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important trophic factors in all organisms. When deprived of a
nitrogen or carbon source, yeast cells use accumulated reserves to
complete the current cycle and arrest at the following G1 phase.
We sought to determine whether phosphate starvation also pro-
vokes G1 arrest. To this end, we transferred exponentially growing
yeast cells from complete medium to a medium lacking a phos-
phate source. The rate of division declined slowly over the next 3 h
(Fig. 1A) and, finally, the cells arrested in G1, as indicated by their
DNA content and budding index (Fig. 1B and C). Interestingly,
the cell cycle arrest was comparable to that observed in the absence
of nitrogen (Fig. 1B) and was not merely a consequence of the
inability to meet the growth requirements of the G1/S transition,
as suggested by the fact that the cell volume still increases under
phosphate deprivation (Fig. 1D).
Considering that cyclins are fundamental to progression through
G1, we asked if the arrest caused by phosphate deprivation requires
downregulation of the activity of G1 cyclins. Cells expressing CLN2
from a constitutive promoter continue to grow in size (not shown)
and, more importantly, cells cross Start despite the absence of phos-
phate, as deduced from the budding index (Fig. 1C). This indicates
that the downregulation of Cln activity may be essential in order to
achieve a proper G1 arrest under phosphate-fasting conditions.
Takentogether, these results strongly suggest that theG1arrest caused
by phosphate deprivation is mediated by specificmechanisms, some
of which involve the downregulation of Cln proteins, and cannot be
explained simply as a passive consequence of a growth arrest that
would prevent cells from reaching the critical cell mass necessary to
bud and to initiate S phase.
FIG 1 Phosphate deprivation leads to G1 arrest. Wild-type cells were grown exponentially in synthetic complete medium. At time zero, cells were harvested and
incubated either in the samemedium (PO4
2) or in amediumwithout phosphate (PO4
2). At the indicated times, samples were collected and then subjected
to several analyses: total cell number (A), DNA content (B), percentage of budding (C), and cell volume (D). (B) The DNA contents of wild-type cells incubated
in a medium without a nitrogen source (N) are shown. (C) The percentages of budding of wild-type cells carrying a centromeric plasmid with the CLN2 gene
expressed from an ADH promoter are shown. Data standard deviations from three independent experiments are shown.
Menoyo et al.
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External phosphate controls the levels of Cln3 protein. Since
constitutive expression of Cln2 could partially reverse the block-
ade in G1, we examined whether the absence of phosphate could
affect the levels of proteins controlling the G1/S transition. The
results in Figure 2A clearly show that the protein levels of Cln2 and
Clb5 (essential for budding and S-phase entry) decrease after 4 h
of growth in phosphate-free medium, whereas the levels of the
protein Sic1 (essential for arresting the cell cycle before S phase)
remain constant. We then analyzed the mRNA levels of all these
genes (Fig. 2B), finding that the mRNA of CLN2 and CLB5 were
also progressively depleted, whereas the transcripts of SIC1 re-
mained constant. These results suggest that the absence of phos-
phate may inhibit the transcription of genes required for the G1/S
transition.
The G1/S transcriptional wave is controlled by the SBF and
MBF factors, which may be regulated by phosphate levels. As ob-
served from the results in Figure 2C, the protein levels of Swi6 are
not affected during the first 6 h after phosphate deprivation (nor
are those of Swi4 or Mbp1 [not shown]), thereby excluding the
possibility that SBF andMBFare controlled at the expression level.
Whi5 and Cln3 are known to play a key role in the activation of
SBF and MBF complexes in late G1 (10). The results in Figure 2C
show that, after 3 h of phosphate depletion, the amount of Cln3
protein decreases rapidly, while the levels of Whi5 repressor re-
main fairly constant. These results support the idea that phos-
phate deprivation downregulates SBF andMBF activity as a result
of the loss of Cln3. Considering that a triple cln mutant cannot
undergo the G1/S transition unless Sic1 is removed (33), we pro-
pose here that the absence of Cln proteins and the sustained pres-
ence of Sic1 may explain the G1 arrest produced by phosphate
deprivation in terms of molecular requirements.
Pho85 activity regulates the levels of Cln3 protein. It is
known that exogenous phosphate activates Pho85, a CDK that
controls the homeostasis of phosphate, and we examined whether
this kinase could also be involved in the control of Cln3 cyclin. As
reflected in Figure 3A, PHO85-depleted cells growing exponen-
tially in rich medium exhibit low levels of Cln3 protein. This de-
crease is very similar to that observed in wild-type cells grown in
phosphate-free medium. PHO85 gene deletion results in a broad
spectrum of defects, and it is possible that our pho85 laboratory
strain bears suppressor mutations that alleviate such defects. To
avoid this problem, we took advantage of the pho85-as strain,
which behaved quite similarly to wild-type cells until the specific
inhibitor 1-Na PP1 was added to the culture. As observed by the
results in Figure 3B, the addition of 1-Na PP1 to the exponentially
growing cells results in a progressive depletion of Cln3 relative to
the amount in control cells. The localization of Pho4-GFP is a
widely used readout to evaluate Pho85 activity (27), and Cln3
starts to decrease at the same time that Pho4-GFP protein enters
the nucleus (not shown). The latter result shows a good correla-
tion between Pho85 inactivation and the reduction of Cln3 pro-
tein and suggests that Pho85 activity (rather than the physical
presence of the protein itself) is a key factor controlling cellular
levels of Cln3.
Upstreamelements of thePHOpathwayalso affectCln3pro-
tein levels. Pho85 activity is controlled by external phosphate
through an upstream signaling transduction pathway that has
been progressively elucidated by several research groups (Fig. 4A)
(for a review, see reference 34). The vip1 and pho81 strains are
unable to respond to changes in the external concentration of
phosphate and therefore, cannot inhibit Pho85 in a deprivation
situation. Thus, we hypothesized that these strains could not
downregulate Cln3 protein levels in response to depletion of
phosphate, which we confirmed experimentally (Fig. 4B). Conse-
FIG 2 Phosphate deprivation leads to the downregulation of Cln3p. (A) Strain YAN32 (triple tagged: Cln2-HA, Clb5-TAP, and Sic1-Myc) was grown
exponentially in synthetic complete medium. At time zero, the cells were harvested and incubated in phosphate (PO4
2)-free medium. At the indicated times,
samples were recovered and then analyzed for different proteins by immunoblotting using specific antibodies. (B) The wild-type strain was treated and sampled
as described in Materials and Methods. Transcripts were analyzed using RT-PCR with specific primers. Data  standard deviations from three independent
experiments are shown. (C) Strains YPC702 (SWI6-TAP), YNR11 (WHI5-TAP), and YNR55 (CLN3-MYC) were treated, sampled, and analyzed as described for
panel A.
Pho85 Controls Cln3 Stability
April 2013 Volume 33 Number 7 mcb.asm.org 1277
 o
n
 M
arch 2, 2016 by Red de Bibliotecas del CSIC
http://m
cb.asm
.org/
D
ow
nloaded from
 
quently, the overexpression of PHO80 has the same effect
(Fig. 4C) as the absence of the inhibitors. All these results strongly
suggest that the phosphate source controls the quantity of Cln3
cyclin by modulating Pho85 activity.
Loss of a particular Pho85 cyclin can phenocopy some aspects
of the phenotype of a pho85mutant, and we decided to evaluate
the levels of Cln3 protein of the different cyclinmutants. As shown
by the results in Figure 4D and E, the pho80 strain is the only one
that shows a reduction in the Cln3 content very similar to that
observed in pho85 cells, suggesting that the effect of the CDK
could bemediated by the Pho80 cyclin. This result is in agreement
with the fact that the Pho80/Pho85 complexes (togetherwith Pcl7/
Pho85) are inhibited when deprived of phosphate (35), providing
further evidence that such nutrients control the quantity of Cln3
by modulating the activity of Pho85 kinase.
Pho85 affects Cln3 stability. Pho85/Pho80 complexes control
the transcription of many genes, and we reasoned that these com-
plexes could modulate the transcription of CLN3 in response to
changes in phosphate levels. However, there are no differences in
the levels of CLN3 mRNA in wild-type cells cultured in the pres-
ence or absence of phosphate (Fig. 5A).
Likewise, we could not detect any changes in the mRNA levels
of CLN3 when comparing wild-type cells, pho85 cells, and cells
that overexpress PHO85. Despite the similar levels of mRNA, we
again confirmed the differences in Cln3 protein levels under these
new experimental conditions (Fig. 5A). These results suggest that
Cln3 must be downregulated by posttranscriptional mechanisms.
Next, we tested whether Pho85 activity affects the stability of
Cln3 by studying the levels of Cln3 in cycloheximide-treated cells.
In wild-type cells, we estimated a Cln3 half-life of 8 min (data not
shown), in accordance with values reported by others (18). Un-
fortunately, we were unable to measure the half-life of Cln3 in the
pho85 strain because of the low levels in these cells. For this
reason, we decided to assess the Cln3 stability in the pho85-as
strain in the presence or absence of the specific inhibitor (Fig. 5B).
Under such conditions, the pho85-as strain still retains low levels
of Pho85 activity but clearly exhibits an apparent reduction in the
half-life of Cln3 protein (5.8 min in control cells versus 3.2 min in
the presence of the inhibitor). Although this result does not ex-
clude the existence of other regulatory mechanisms (such as the
control of the translation of Cln3mRNA), it strongly suggests that
Pho85 activity increases the stability of the cyclin.
Pho85 does not control Cln3 stability through regulation of
autophagy. It has been recently described that Pho85 negatively
regulates autophagy through diverse mechanisms (36). Au-
tophagy induces the destruction of many proteins under condi-
tions of nutrient deprivation, and we hypothesized that Cln3
could be a likely candidate for destruction. To test this hypothesis,
we quantified the Cln3 levels in a pho85 strain whose autophagy
process has been abrogated the (pho85 atg1 strain) and found
that the Cln3 protein levels still were clearly decreased (Fig. 5C).
This result rules out the possibility that Pho85 controls Cln3 sta-
bility through the regulation of autophagy.
Pho85 affects Cln3 ubiquitin-dependent degradation. Since
Cln3 is constitutively degraded by a ubiquitination-dependent
mechanism (9), we decided to test whether Pho85 controls this
process. We found 2 pieces of experimental evidence to support
this hypothesis: (i) deletion of the PEST region in CLN3 (the
cln3-1 allele; see the legend to Fig. 6A), which has been shown to
prevent ubiquitination, also stabilizes the protein, even in the
pho85 strain (Fig. 5D), and (ii) deletion of the E2 ubiquitin ligase
Ubc4, which is important for nutrient homeostasis and is involved
in the ubiquitination of Cln3 (9), restores Cln3 levels in the
pho85 strain (Fig. 5E). Therefore, Pho85may somehow interfere
with Cln3 ubiquitination and/or destruction processes. Bearing in
mind that Pho85 is a protein kinase, one explanation could be that
it phosphorylates Cln3 and thereby interferes with such processes.
Cln3 is an in vitro substrate of Pho80/Pho85.To test the latter
hypothesis, we performed an in vitro phosphorylation experi-
ment, for which we needed to obtain full-length Cln3 protein.We
tried to purify Cln3 from wild-type yeast cells, but the cyclin is
tightly associated with the endoplasmic reticulum (37) and re-
mains with the particulate fraction of the cell extracts, making
purification difficult. We also tried to purify it as a recombinant
protein, but the expression of the full-length protein was highly
toxic to E. coli cells, resulting in very poor expression levels. Fi-
nally, we expressed and purified a fragment of the recombinant
GST-Cln3 protein (fromMet347 to Arg580) containing the PEST
region. This fragment of Cln3 was specifically phosphorylated by
reconstituted Pho85/Pho80 complexes purified from E. coli cells
(Fig. 6B). In contrast, we observed that the N-terminal half of the
Cln3 protein (from Met1 to Met347) was not phosphorylated by
Pho85 (not shown).
Pho85 is a proline-directed kinase that preferentially phosphor-
ylates the consensus sequence S/T-P-X-I/L (17), and Cln3 con-
tains twoof these sites (Ser449 andThr520) located precisely at the
ends of the PEST region (Fig. 6A). We replaced both of these sites
with either alanine or aspartic acid, rendering Cln3 that was no
longer phosphorylated by Pho85 (Fig. 6B) and showing S449 and
T520 to be the Pho85/Pho80 targets. A typical substrate of Pho85/
Pho80, such as Pho4, was included as a control.
FIG 3 Pho85 inactivation leads to downregulation of Cln3. (A) Wild-type
(wt) and pho85 cells were grown exponentially in YPD and then assessed for
levels of Cln3-Myc (left), andwild-type cells were grown in synthetic complete
medium with (PO4
2) or without (PO4
2) phosphate (right). Samples
were taken after 6 h, and levels of Cln3-Myc were monitored. (B) Cells from
the YAM67 strain were incubated with either 1-Na PP1 (a specific pho85-as
inhibitor) or drug vehicle (dimethyl sulfoxide [DMSO]). Samples were taken
at the indicated times, and Cln3-Myc was analyzed by immunoblotting.
Data  standard deviations from three independent experiments are shown.
Cln3p, phosphorylated Cln3.
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It has been suggested that Cdc28 is involved in the down-
regulation of Cln3 levels by acting through the CDK consensus
phosphorylation sites in the PEST region of Cln3. Therefore,
Cln3 phosphorylation by Cdc28 and Pho85 appears to have the
opposite effect. We assayed the same Cln3 fragments against
Cdc28-TAP immunopurified from yeast cells. The results in
Figure 6C show that Cdc28 phosphorylates Cln3 (to a greater
extent than Pho85, probably because it phosphorylates Cln3 at
more sites in the PEST region). Interestingly, Cdc28 is still able
to phosphorylate the S449A T520A cln3 mutant to the same
extent as the wild type (Fig. 6C), indicating a differential site
requirement between Cdc28 and Pho85 on Cln3, at least in
vitro. A typical substrate of Cdc28, such as Sic1, is included as a
control.
Because Cln3 and Pho80 interact in vivo, as indicated by the
results of coimmunoprecipitation experiments (Fig. 7A), we ex-
amined whether Cln3 is also an in vivo substrate of Pho85.
In vivo phosphorylation of S449 and T520 is essential to
maintain Cln3 levels. We verified the in vivo Cln3 phosphoryla-
tion status by using mobility shift analysis. However, unphosphor-
ylated Cln3 is highly unstable and becomes nearly undetectable by
Western blot analysis, making this experiment very challenging.
We attempted to identify the shift using a pho85-as strain and
adding 5 times more yeast extract to the electrophoresis gel, but
the levels of Cln3 remained nearly undetectable (data not shown).
We decided to test the in vivo effects of phosphorylation by
measuring the levels of different mutant versions of Cln3. We
expressed Cln3 from its own promoter in a centromeric plasmid,
and when we replaced S449 and T520 with alanines, the levels of
Cln3 became nearly undetectable (Fig. 7B and C). We also re-
placed these 2 sites with aspartic acid, to mimic the effect of phos-
phorylation, predicting that they would restore Cln3 levels to
some degree in a strain without Pho85 activity. The results in
Figure 7D and E illustrate how in pho85 cells (or in wild-type
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FIG 4 Phosphate controls cellular levels of Cln3 bymodulating the PHOpathway. (A) Schematic of the PHOpathway.During phosphate starvation, Vip1 causes
an increase in the levels of inositol heptakisphosphate (IP7), which binds to and changes the conformation state of Pho81, leading to the inactivation of
Pho85/Pho80 complexes. (B) Relative amounts of Cln3-Myc in different strains. Wild-type (wt), pho81, and vip1 strains were grown in synthetic complete
medium with (PO4
2) or without (PO4
2) phosphate. After 5 h, the levels of Cln3-Myc were quantified by immunoblotting using monoclonal antibodies.
Cells of the Gal1-PHO85 strain (a wild-type strain that carries a centromeric plasmid with PHO85 expressed under the Gal1 promoter) were grown for 5 h in
synthetic complete medium with galactose as a carbon source, either with or without phosphate. (C) Pho80 is necessary to maintain high levels of Cln3. As
described for panel B, wild-type (GAL-Ø) and GAL1-PHO80 strains were grown in synthetic complete medium in the presence of galactose without phosphate
(PO4
2). Levels of Cln3-Myc were quantified by immunoblotting using monoclonal antibodies. (D) Pho80 is necessary to maintain high levels of Cln3.
Quantification of data in panel E (data standard deviations from four independent experiments) is shown. (E) Pho80 is necessary to maintain high levels of
Cln3. A plasmid with a Cln3-Myc epitope tag was introduced in strains with the indicated mutations for deficiency of the different Pho85 cyclins. After 3 h of
exponential growth in YPD, the levels of Cln3-Myc were analyzed by immunoblotting.
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cells growing in medium without phosphate), the levels of Cln3
carrying the S449 and T520 aspartic acid substitutions are higher
than the levels of wild-type Cln3, suggesting that in vivo phos-
phorylation at these sites is essential for maintaining high levels of
Cln3. Overall, these results suggest that the proposed phosphory-
lation sites are involved in the in vivo regulation of Cln3 levels.
A possible scenario that emerges from all these results (Fig. 8A)
is that in the absence of phosphate, Pho85 becomes inactive and
Cln3 is no longer phosphorylated, which in turn would interfere
with the ubiquitination and/or the destruction of the cyclin. At
this point, we sought to test the physiological validity of our pro-
posed model.
Pho85 inactivation is essential for proper G1 arrest. Ectopic
expression of Cln3 in G1-arrested cells (due to the presence of
rapamycin or to nutrient depletion) leads to accidental entry into
S phase and to diminished cell viability (38, 39). To ascertain the
relevance of these observations to our work, we arrested cells in
phosphate-depleted medium, and we found that, as predicted,
cells with a hyperactive form ofCLN3 (the cln3-1 allele) induced a
diminished cell viability which correlated well with an increase in
the number of cells that crossed Start, as indicated by the high
percentage of budded cells (Fig. 8B).Moreover, as discussed above
(Fig. 1), ectopic expression of Cln2 led to a clear increase in the
number of budded cells and to a rise in the rate of cell death (not
shown). Hence, it seems that downregulation of Cdc28 activity is
essential for proper G1 arrest during phosphate deprivation.
According to our model, overactivation of Pho85 should also
be detrimental to cell viability in G1-arrested cells, and our results
demonstrated that this was indeed the case. As shown by the re-
sults in Figure 8B, wild-type cells incubated for 7 days in phos-
phate-free medium exhibited a viability rate of 55%. In contrast,
vip1 or pho81 cells (which should retain Pho80/Pho85 activity
under the same conditions of deprivation) showed an increase in
improperly arrested cells (16 to 18% of budded cells) and a signif-
icant loss in viability (a total of 20%). Evenmore interesting is the
fact that cells carrying the Cln3 with the Asp substitutions that
mimic Pho85 phosphorylation also have low viability under phos-
phate-fasting conditions. Together, these results agree with the
FIG 5 Pho85 activity increases the half-life of Cln3 protein. (A) Different strains with a genomic tagged version of CLN3 were sampled and then analyzed for
CLN3mRNA levels (by RT-PCR) or Cln3-Myc levels (by immunoblotting). Wild-type cells were grown exponentially in synthetic complete medium with (wt)
or without (wtPO4
2) phosphate, pho85 strain cells were grown in the same complete medium with phosphate, and GAL-PHO85 cells were grown for 5 h
in synthetic complete medium with galactose as a carbon source. (B) YAM67 strain cells were incubated with either 1-Na PP1 (a specific pho85-as inhibitor) or
drug vehicle (DMSO). Forty minutes later (time zero), cycloheximide (CHX) was added to the cultures (final concentration, 10 g/ml). At the indicated times,
samples were taken and analyzed for Cln3-Myc levels by immunoblotting. Data  standard deviations from four independent experiments are shown. t1/2,
half-life. (C) Downregulation of autophagy does not restore the diminished Cln3 levels of pho85 mutants. Strains of the indicated genotypes were grown
exponentially in phosphate-rich medium, and Cln3-Myc was analyzed by immunoblot assay using specific antibodies. (D) Absence of the PEST region restores
Cln3 levels in pho85 cells. Wild-type or pho85 cells carrying a plasmid with a cln3-1 allele without the PEST region (41) were grown exponentially in YPD.
Cln3-HA levels were measured by immunoblotting. (E) Absence of UBC4 restores Cln3 levels in a pho85 strain. Strains of the indicated genotypes carrying a
genomic Myc-tagged version of Cln3 were grown exponentially in phosphate-rich medium. Cells were harvested, and Cln3 levels were evaluated by immuno-
blotting.
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notion that, in the absence of phosphate, downregulation of
Pho85 activity is essential for decreasingCln3 levels and for proper
G1 arrest.
Pho85 activation is essential for proper cell cycle reentry. It
has been proposed that Pho85 activity is essential in situations
with no Cdc28 activity, such as those involving cell cycle restart
(20). This hypothesis is consistent with our model, which, if true,
predicts that cells with low Pho85 activity should have difficulties
reentering the cell cycle from G0. To test this prediction, we incu-
bated yeast strains in phosphate-freemedium and, after 7 h, trans-
ferred them to richmedium in order tomonitor their growth. The
results in Figure 8C show how, after 2 h of incubation in phos-
phate-rich medium, pho85 cells present low levels of Cln3 and
consequently remain arrested, while wild-type cells already un-
dergomitosis. It is interesting to note that the differences between
strains are only minor when we compare the ability of cell cycle
reentry from -factor arrest (Fig. 8D). This finding suggests that
the observed delay in cell cycle reentry is specific rather than a
general defect of cell cycle regulation.
In summary, these results reinforce the idea that Pho85 activity
plays an indispensable role in exiting from G0 arrest.
DISCUSSION
Phosphate levels regulate cell cycle progression. So far, there are
several lines of evidence implicating glucose and nitrogen as crit-
ical elements in cell cycle control and that their absence leads toG1
arrest. Also, it is known that the absence of phosphate also stops
proliferation. At first glance, one might assume that this defect is
merely a nonspecific consequence arising from the reduction in
the level of a particular metabolite (e.g., ATP). However, there is
considerable evidence to confirm that the observed arrest is a con-
trolled process, as follows. (i) Under phosphate-fasting condi-
tions, the cells accumulate as mostly unbudded with 1N DNA
content; if they had arrested accidentally, we should have found
cells in various stages of the cycle. (ii) Metabolomic studies have
shown that cells growing under phosphate-limiting conditions
maintain a relatively constant free energy of ATP hydrolysis (40),
suggesting that in the first moments of phosphate deprivation,
cells might have enough energy to initiate an adaptive response,
such as finishing one round of division until the next G1 phase.
(iii) The volume of arrested cells continues to increase, indicating
that they are metabolically active and not in a collapsed state. (iv)
Finally, the arrest caused by lack of phosphate can be reversedwith
an increase in CDK/Cln2 activity. In conclusion, one of the con-
tributions of the present work is to confirm that phosphate regu-
lates Start through the control of G1/S transcriptional machinery
in S. cerevisiae, as suggested some time ago by Johnston et al. (35).
It should be noted that, in our experiments, the cells did not
arrest immediately: they gradually accumulated in the G1 phase,
and finally, within approximately 6 h of deprivation, 90% of them
had stopped dividing. This gradual response of cultures is proba-
bly due to polyphosphate reserves in the cells (41) which serve to
buffer the sudden external changes.
Pho85 affects the stability of Cln3. The central idea of this
work is that phosphate levels dictate Cln3 stability by regulating
the activity of the Pho85/Pho80 complex. It is interesting to note
that the amounts of other cyclins (e.g., Cln2) are not affected by
Pho85 activity (not shown), underscoring the specificity of the
described effect.
Several studies indicate that Cln3 is downregulated by transla-
tional repression under conditions of nutrient deprivation (18, 42,
43). Although we cannot rule out the possibility that phosphate
limitation has the same effect, our results show that the critical
step targeted by phosphate availability on Cln3 is its stability. An
analogous destabilization phenomenon has been described in ni-
trogen-deprived cells, although its mechanism remains unex-
plained (18). This same study showed that the half-life of Cln3was
again reduced by half. Thus, the destabilization of Cln3, along
FIG 6 Cln3 is phosphorylated in vitro by Pho85/Pho80. (A) Schematic representation of Cln3 with the different functional domains. The PEST region is
indicated by shading, and the putative target residues for Pho85 by arrows. NLS, nuclear localization signal. (B) In vitro kinase assay of Pho85/Pho80 on Cln3.
Recombinant Pho85 and GST-Pho80, purified from bacteria, were incubated with the C-terminal half of Cln3 (also from bacteria) containing the PEST region
with the indicated mutations or the wild-type sequence (see Materials and Methods and Table 2). Pho4, a well-known substrate of Pho85/Pho80, was included
as a control for the Pho85/Pho80 activity. The arrows indicate Cln3 protein. (C) In vitro kinase assay of Cdc28-TAP and the Cln3 mutants with the indicated
mutations or the wild-type sequence. IgG-Sepharose beads were used to pull down Cdc28 either from a no-tag strain () or the Cdc28-TAP tag strain (). Sic1
was included as a control for the Cdc28 kinase activity.
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with its possible translational repression, could be a general re-
sponse of the cell against the limitation of different nutrients. This
would limit the activity of theCln3/Cdc28 complex needed to pass
Start in order to slow down the cell cycle and to adapt to the new
conditions.
The finding that Cln3 is affected by Pho85/Pho80 activity is
relevant for two reasons: on one hand, the Pho85/Pho80 route is
shown for the first time to be involved in directly controlling the
cell cycle machinery, suggesting coordination between phosphate
homeostasis and the cell cycle, and on the other hand, to our
knowledge, this is the first reported case of one CDK controlling
the activity of another. Interestingly, during the revision process
of the manuscript, the group of Kron and collaborators described
that Pho85/Pcl2 controlled the amount of Cln3 through the acti-
vation of Hsp70 in response to nitrogen, pointing to Pho85 as a
general controller of Cln3 in response to variations in nutrient
levels (44).
How does Pho85 affect the stability of the cyclin Cln3? Having
excluded the possibility of autophagy, we propose here that Cln3
FIG 7 In vivo phosphorylation of S449 and T520 is essential to maintain Cln3
levels. (A) Pho80 and Cln3 interact in vivo. Yeast extracts (WCE [whole-cell
extracts]) containing untagged Pho80 or Pho80-TAP were pulled down with
IgG-Sepharose. Tagged Cln3-Myc (from its chromosomal locus) was detected
using specific antibodies (IP [immunoprecipitate]). (B) Alanine replacement
of S449 and T520 destabilizes Cln3. Wild-type cells were transformed with a
centromeric plasmid bearing a Cln3-Myc or a 2-Ala (S449A T520A) mutant
version and grown for 4 h in rich medium. The amount of Cln3 was deter-
mined by immunoblotting. (C) Quantification of experiment whose results
are shown in panel B. Data standard deviations of three independent exper-
iments are shown. (D) Aspartic acid replacement of S449 and T520 stabilizes
Cln3. Wild-type (in phosphate-deficient medium) or pho85 (in phosphate-
rich medium) cells bearing a plasmid with different versions of CLN3 were
grown exponentially for 4 h. Cln3 levels were analyzed by immunoblotting. To
simplify the nomenclature, S449Dmeans a double substitution of Asp into the
Ser 449 and the previous residue to mimic the double-negative charge that
represents the phosphate group (see Materials and Methods), and the same is
true for T520D. (E) Quantification of experiments whose results are shown in
panel D. Data  standard deviations of three independent experiments are
shown.
FIG 8 Pho85 activity is necessary for proper G1 arrest and cell cycle reentry.
(A) Proposed model of Pho85 activity. In phosphate-rich medium, Pho85/
Pho80 complexes remain highly active. Under such conditions, Pho85 phos-
phorylates and inactivates Pho4 and Rim15 (25) and, conversely, activates
cyclin Cln3. (B) Proper regulation of Pho85 activity is essential for survival
under conditions of phosphate deprivation. Cells were incubated in synthetic
complete medium for 7 days, at which point cells were collected and assessed
for viability by colony counting (left). The percentage of buddingwas analyzed
by counting no less than 200 cells under the microscope (right). Data stan-
dard deviations from three independent experiments are shown. (C) Pho85
activity is necessary for reentry into the cell cycle after refeeding. Cells trans-
formed with a centromeric plasmid bearing Cln3-Myc were deprived of phos-
phate for 7 h (time zero) and then refed. At various times, samples were col-
lected and analyzed forDNAcontent by flow cytometry (top). Times (min) are
indicated at left; “PO4
2” indicates the initiation of refeeding. Cln3 levels
were monitored by immunoblotting (bottom) at times (min) indicated above
the gel. (D) pho85 progresses through G1, with a small delay, after -factor
exit. Wild-type and pho85 cells were synchronized with -factor for 3 h and
then released into fresh medium at 30°C. At various times, samples were col-
lected. Times (min) are indicated at left; “-factor release” indicates the time of
release following synchronization. Total DNA content was measured as de-
scribed in Materials and Methods, except that propidium iodide was used
instead of SYBR green.
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phosphorylation by Pho85may somehow hinder the normal deg-
radation of Cln3. This raises the possibility that phosphorylation
of Cln3 complicates its recruitment by the ubiquitination system,
consequently expanding its lifetime. The idea that phosphoryla-
tionmay prevent interaction with E3 ligases has already been sug-
gested for other cell cycle-regulated proteins (45).
If Cdc28 and Pho85 have opposite effects on Cln3 stability,
then it would be important to determine whether these CDKs
phosphorylate different residues. The residues of Cln3 phosphor-
ylated by Cdc28 are currently unknown, although some results
point to S468 as one of themost likely candidates (9).However, we
have demonstrated that a recombinant fragment of Cln3 that
presents S449 and T520mutated to alanine is still phosphorylated
by Cdc28 and is no longer phosphorylated by Pho85 (Fig. 6B and
C), indicating that the CDKs phosphorylate different residues of
Cln3, at least in vitro. It is important to note that, although the
consensus sequence for the CDK family is SP or TP, Cdc28 and
Pho85 have distinct preferences for the sequence adjacent to these
sites. Cdc28 prefers a positively charged lysine or arginine at the
third position from the phosphoacceptor site, with the consensus
site being S/TPXK/R (46, 47), whereas Pho80-Pho85 has the con-
sensus phosphorylation site sequence SPXI/L (24, 48). Therefore,
it is formally plausible that both kinases phosphorylate distinct
sites, generating distinct effects. In this regard, it is interesting to
note that only 2 of 10 SP/TP sites of the PEST region have the
preferred sequence for Pho85 (the hydrophobic residue at 3),
and these sites are the same two that appear to be phosphorylated
by Pho85. There are other examples of proteins that are phosphor-
ylated at SP/TP with opposite effects, such as Sic1, which must
exceed a threshold of CDK phosphorylation in several SP/TP sites
to be destroyed, but a single mitogen-activated protein kinase
(MAPK) phosphorylation in one specific TP makes the protein
stable (45).
Physiological significance ofCln3 regulation.Theunderlying
mechanism(s) that enables nutrient sensors to control cell cycle
machinery remains unknown. Organisms may need to employ
several convergent mechanisms to provoke complete G1 arrest,
making the identification of a single molecular target rather diffi-
cult. We propose that modulation of Cln3 stability may be one of
many principal targets in cell cycle regulation, at least in terms of
the adaptive response to phosphate scarcity (the proposed model
is shown in Fig. 8A). Cln3 cyclin is a good candidate because it is
the most upstream control point in the cell cycle and because
raising its cellular content by either increased transcription or al-
tered protein turnover profoundly affects its capacity to pass
through G1 (9, 49). Thus, the G1 arrest caused by phosphate de-
privation could be explained by a simple model: due to the reduc-
tion in the Cln3 half-life, starved cells cannot reach the Cln3
threshold level required to execute the Start program. However,
this mechanism might not be important in rich medium, given
that cln3 cells can still progress through the entire cell cycle,
albeit with a longer G1 phase.
According to our model, Cln3 destabilization is crucial during
G1 arrest due to lack of phosphate. This downregulation could be
important, for instance, in maintaining silencing of Swi6-depen-
dent transcription in order to avoid the process of wall remodeling
during nutrient deprivation (50). Moreover, Burhan’s group has
demonstrated that establishing and maintaining proper arrest in
G1 is an important cellular response to nutrient deprivation (38);
they report that cells that improperly halt at the S phase suffer
replication stress and rapidly lose viability. Furthermore, they
clearly demonstrate that ectopic expression of CLN3 increases the
frequency with which nutrient-depleted cells arrest at the begin-
ning of the S phase instead of G1. Our results confirm that the
presence of a hyperstable Cln3 allele (cln3-1) also increases the
number of S-phase-arrested cells and decreases cell viability. In
this context, we propose that in response to the lack of phosphate,
Pho85 inactivation is critical for stopping the cycle at G1, avoiding
entry into the S phase with low levels of nucleotides. This assump-
tion is clearly supported by evidence showing that mutants with
high Pho85 activity (pho81, vip1, and Gal-PHO85) incubated
inmediumwithout phosphate (i)maintain high levels of Cln3, (ii)
show large numbers of cells that have entered the cell cycle, and
(iii) show a decrease in cell viability. Considering that under the
same conditions of deprivation, cells with a CLN3 allele that en-
codes aspartic acid substitutions also die prematurely, we propose
that such cellular defects chiefly derive from sustained and un-
scheduled phosphorylation of Cln3.
According to our model, Pho85 could also be important for
restarting the cell cycle after refeeding. Our findings support this
notion; either the absence of Cln3 or low Pho85 activity greatly
hinders reentry into the cell cycle. Interestingly, this role for Pho85
in reentry seems to be specific, as reflected in the almost total lack
of differences between wild-type cells and pho85 cells released
from alpha factor arrest. These results are consistent with the hy-
pothesis that Pho85 is essential whenCdc28 activity is lacking (20)
and reinforce the idea that Pho85 activity is almost dispensable
when yeast grows in nutrient-richmedium (although the cells still
undergo a longer G1 phase), but is essential in other situations
(e.g., exiting from nutrient-induced G0 arrest). Since wild yeast
should thrive under diverse nutrient conditions (the availability of
phosphate and other nutrients often varies widely), we postulate
that Pho85 must be fundamental in controlling the constant cell
cycle stalls and reentries that a yeast cell is subjected to under
natural conditions.
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